AI In-Brief
Thailand News in Brief
Thai PBS World
Thailand and the world, every day
AI can make mistakes. Please double-check.
Thai FDA approves use of Covovax and Spikevax vaccines in younger people
13 Sept 09:49 Key points summarised by AI
- Thai FDA expands vaccine eligibility, approving Covovax (Novavax formulation) for adolescents aged 12-17 and Moderna's Spikevax for children aged 6-11.
- Specific dosages outlined: Covovax for 12-17 year olds involves two 0.5ml doses three weeks apart, while Spikevax for 6-11 year olds uses two 0.25ml doses (half adult dose) four weeks apart.
- This timely approval aims to boost vaccination rates among younger populations ahead of the nationwide resumption of on-site classes on May 17th, given current low vaccination coverage for children aged 5-11.
